Cargando…
Disopyramide for Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a cardiac disease characterized by hypertrophy of a nondilated left ventricle without any other cardiac or systemic disease that could account for observed hypertrophy. We present a female patient with the diagnosis of obstructive HCM, which is rare because sudde...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592455/ https://www.ncbi.nlm.nih.gov/pubmed/31263635 http://dx.doi.org/10.7759/cureus.4526 |
_version_ | 1783429885076701184 |
---|---|
author | Sanchez-Nadales, Alejandro Anampa-Guzmán, Andrea Khan, Amir |
author_facet | Sanchez-Nadales, Alejandro Anampa-Guzmán, Andrea Khan, Amir |
author_sort | Sanchez-Nadales, Alejandro |
collection | PubMed |
description | Hypertrophic cardiomyopathy (HCM) is a cardiac disease characterized by hypertrophy of a nondilated left ventricle without any other cardiac or systemic disease that could account for observed hypertrophy. We present a female patient with the diagnosis of obstructive HCM, which is rare because sudden death is frequently the first clinical presentation. Her symptoms were resistant to medical treatment and the patient did not want invasive procedures. Disopyramide was added, and it improved her symptoms. Disopyramide is a safe and effective medication that reduces symptoms and delays the need for invasive therapy. Disopyramide was added to the treatment of the patient and it improved her symptoms. |
format | Online Article Text |
id | pubmed-6592455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-65924552019-07-01 Disopyramide for Hypertrophic Cardiomyopathy Sanchez-Nadales, Alejandro Anampa-Guzmán, Andrea Khan, Amir Cureus Cardiac/Thoracic/Vascular Surgery Hypertrophic cardiomyopathy (HCM) is a cardiac disease characterized by hypertrophy of a nondilated left ventricle without any other cardiac or systemic disease that could account for observed hypertrophy. We present a female patient with the diagnosis of obstructive HCM, which is rare because sudden death is frequently the first clinical presentation. Her symptoms were resistant to medical treatment and the patient did not want invasive procedures. Disopyramide was added, and it improved her symptoms. Disopyramide is a safe and effective medication that reduces symptoms and delays the need for invasive therapy. Disopyramide was added to the treatment of the patient and it improved her symptoms. Cureus 2019-04-23 /pmc/articles/PMC6592455/ /pubmed/31263635 http://dx.doi.org/10.7759/cureus.4526 Text en Copyright © 2019, Sanchez-Nadales et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiac/Thoracic/Vascular Surgery Sanchez-Nadales, Alejandro Anampa-Guzmán, Andrea Khan, Amir Disopyramide for Hypertrophic Cardiomyopathy |
title | Disopyramide for Hypertrophic Cardiomyopathy |
title_full | Disopyramide for Hypertrophic Cardiomyopathy |
title_fullStr | Disopyramide for Hypertrophic Cardiomyopathy |
title_full_unstemmed | Disopyramide for Hypertrophic Cardiomyopathy |
title_short | Disopyramide for Hypertrophic Cardiomyopathy |
title_sort | disopyramide for hypertrophic cardiomyopathy |
topic | Cardiac/Thoracic/Vascular Surgery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592455/ https://www.ncbi.nlm.nih.gov/pubmed/31263635 http://dx.doi.org/10.7759/cureus.4526 |
work_keys_str_mv | AT sancheznadalesalejandro disopyramideforhypertrophiccardiomyopathy AT anampaguzmanandrea disopyramideforhypertrophiccardiomyopathy AT khanamir disopyramideforhypertrophiccardiomyopathy |